Double-Blind Randomized Controlled Trial of Rifaximin for Persistent Symptoms in Patients with Celiac Disease

By Chang Matthew  

Digestive Diseases and Sciences, Vol. 56, Iss. 10, 2011-10 ,pp. : 2939-2946

Springer Publishing Company

Access to resources Recommend Favorite

One year comparison between two add‐back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double‐blind trial

By Fernandez H.  

Human Reproduction, Vol. 19, Iss. 6, 2004-06 ,pp. : 1465-1471

Oxford University Press

Access to resources Recommend Favorite

Geranylgeranylacetone Protects against Diclofenac-Induced Gastric and Small Intestinal Mucosal Injuries in Healthy Subjects: A Prospective Randomized Placebo-Controlled Double-Blind Cross-Over Study

By  

Digestion, Vol. 80, Iss. 4, 2009-10 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

By Matsueda Kei   Harasawa Shigeru   Hongo Michio   Hiwatashi Nobuo   Sasaki Daisuke  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 10, 2008-01 ,pp. : 1202-1211

Informa Healthcare

Access to resources Recommend Favorite

Effects of l-Acetylcarnitine on Cirrhotic Patients with Hepatic Coma: Randomized Double-Blind, Placebo-Controlled Trial

By Malaguarnera Mariano   Pistone Giovanni   Astuto Marinella   Vecchio Ignazio   Raffaele Rocco   Lo Giudice Emilia   Rampello Liborio  

Digestive Diseases and Sciences, Vol. 51, Iss. 12, 2006-12 ,pp. : 2242-2247

Springer Publishing Company

Access to resources Recommend Favorite